BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18400243)

  • 1. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
    Malinowsky K; Luksza J; Dittmar MT
    Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dominant-negative action of a fusion protein containing the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 in virus replication.
    Chan WE; Chen SS
    J Biomed Sci; 2007 Nov; 14(6):717-29. PubMed ID: 17610148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells.
    Lodge R; Lalonde JP; Lemay G; Cohen EA
    EMBO J; 1997 Feb; 16(4):695-705. PubMed ID: 9049299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.
    Chen SS; Yang P; Ke PY; Li HF; Chan WE; Chang DK; Chuang CK; Tsai Y; Huang SC
    J Virol; 2009 Jan; 83(2):870-83. PubMed ID: 18987155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor.
    Vigerust DJ; Egan BS; Shepherd VL
    J Leukoc Biol; 2005 Apr; 77(4):522-34. PubMed ID: 15637102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
    Celma CC; Paladino MG; González SA; Affranchino JL
    Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
    Miyauchi K; Komano J; Yokomaku Y; Sugiura W; Yamamoto N; Matsuda Z
    J Virol; 2005 Apr; 79(8):4720-9. PubMed ID: 15795258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
    Kinomoto M; Yokoyama M; Sato H; Kojima A; Kurata T; Ikuta K; Sata T; Tokunaga K
    J Virol; 2005 May; 79(10):5996-6004. PubMed ID: 15857986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
    J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
    Chan WE; Chen SS
    Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
    Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
    J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
    Chen P; Hübner W; Riviere K; Liu YX; Chen BK
    Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells.
    Shiraishi T; Misumi S; Takama M; Takahashi I; Shoji S
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1201-5. PubMed ID: 11302743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.